TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

NCT03745651 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

618

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Ruxolitinib cream
DRUG: Vehicle cream

Sponsor

Incyte Corporation